Keeping the business world informed
Antibody-Dependent Enhancement and How it Relates to the Current COVID-19 Pandemic
One of the most disconcerting aspects of the COVID-19 pandemic is the wide range of presentations that occur across patients. Some are asymptomatic, only finding out that they had the virus through antibody testing, while others can have severe respiratory syndromes requiring a ventilator to stay alive. Outside of predisposing factors like age and comorbidities, it is seemingly random who will struggle and who won’t. While this phenomenon may still baffle us, there is a possible explanation of what is causing such severe lung damage in the most serious cases. The proposed mechanism deals with a process called an antibody-dependent enhancement, and it may have implications in both treating patients with acute infection and the development of a COVID-19 vaccine in the future.
Transmission of COVID-19 on Surfaces
As the pandemic continues, many people are more aware of the importance of maintaining clean surfaces within their homes, businesses, and shared spaces. Determining which surfaces might hold viral material longer than others is vital. Several studies have been conducted, none perfect, but could potentially shed better light on this important concern.
With the reopening of schools this fall being left mainly to individual districts rather than set nationwide standards, many different approaches have been put forth to tackle this issue. There are a handful of changes that research states should be widely adopted to increase the safety of students, faculty, and staff.
Mental Health: The Impact of COVID-19
SARS-CoV-2, the virus that causes COVID-19, has not only affected physical health, but the mental health of individuals. It is important to recognize and acknowledge the impact this virus has on mental health to be able to better understand and help those affected.
Cardiovascular Effects of COVID-19
It has been hypothesized that individuals who control their blood pressure using ACE inhibitors or ARBs are at a higher risk of contracting the disease and are at higher risk to develop adverse effects from it. It is important to debunk this myth because a large portion of the U.S. society is on those medications